entity

TH, AADC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TH, AADC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections
1Hypotheses
1Analyses
5Outgoing
11Incoming

Wiki Pages (20)

Knowledge base pages for this entity

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Device Therapies Comparison for CBS/PSP

therapeutic · 6867 words

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

therapeutic · 5600 words

lithium-tauopathy

therapeutic · 4282 words

Section 147: Telehealth and Remote Monitoring in CBS/PSP

therapeutic · 4197 words

Outgoing (5)

TargetRelationTypeStr
TLR4, SNCAdebate_co_mentiongene0.45
neurodegenerationassociated_withdisease0.40
neurodegenerationimplicated_indisease0.40
TLR4, SNCAco_associated_withgene0.40
benchmark_ot_ad_answer_key:TH, AADCdata_indataset_row0.00

Incoming (11)

SourceRelationTypeStr
h-7bb47d7atargetshypothesis0.50
NLRP3debate_co_mentiongene0.45
NLRP3, CASP1, IL1B, PYCARDdebate_co_mentiongene0.45
SNCAdebate_co_mentiongene0.45
SNCA, HSPA1A, DNMT1debate_co_mentiongene0.45

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis 0.364 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.617

Related Papers (18)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Gene therapy for Parkinson's disease: current landscape, translational challenge [PMID:41837837] Evola V, Parmar MS Expert review of neurotherapeu 2026 0
Neurosurgical gene therapy for central nervous system diseases. [PMID:39191071] Patel RV, Nanda P, Richardson RM Neurotherapeutics : the journa 2024 0
Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC d [PMID:34763085] Tai CH, Lee NC, Chien YH, Byrne BJ, Mura Molecular therapy : the journa 2022 0
Gene therapy restores dopamine transporter expression and ameliorates pathology [PMID:34011628] Ng J, Barral S, De La Fuente Barrigon C, Science translational medicine 2021 0
Current Clinical Applications of In Vivo Gene Therapy with AAVs. [PMID:33309881] Mendell JR, Al-Zaidy SA, Rodino-Klapac L Molecular therapy : the journa 2021 0
Targeting autophagy using small-molecule compounds to improve potential therapy [PMID:34729301] Zhang K, Zhu S, Li J, Jiang T, Feng L, P Acta pharmaceutica Sinica. B 2021 0
Graphene bilayers with a twist. [PMID:33208935] ["Andrei E", "MacDonald A"] Nature materials 2020 0
Reconstruction of cell spatial organization from single-cell RNA sequencing data [PMID:32541867] ["Ren X", "Zhong G", "Zhang Q", "Zhang L Cell research 2020 0
Gene therapy for neurodegenerative disorders: advances, insights and prospects. [PMID:32963936] Chen W, Hu Y, Ju D Acta pharmaceutica Sinica. B 2020 0
Ligand entry in human ileal bile acid-binding protein is mediated by histidine p [PMID:30886237] ["Horv\u00e1th G", "Egyed O", "Tang C", Scientific reports 2019 0
[Skin Changes in POEMS Syndrome]. [PMID:30988219] ["Kuwabara S"] Brain and nerve = Shinkei kenk 2019 0
Consensus guideline for the diagnosis and treatment of aromatic l-amino acid dec [PMID:28100251] Wassenberg T, Molero-Luis M, Jeltsch K, Orphanet journal of rare disea 2017 0
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecho [PMID:27491309] Nagatsu T, Nagatsu I Journal of neural transmission 2016 0
Large-scale meta-analysis of genome-wide association data identifies six new ris [PMID:25064009] ["Nalls M", "Pankratz N", "Lill C", "Do Nature genetics 2014 0
Reward and aversion in a heterogeneous midbrain dopamine system. [PMID:23578393] Lammel S, Lim BK, Malenka RC Neuropharmacology 2014 0
Differential modulation of innate immunity in vitro by probiotic strains of Lact [PMID:24365457] ["Luongo D", "Miyamoto J", "Bergamo P", BMC microbiology 2013 0
Antiparkinson prodrugs. [PMID:18259129] Di Stefano A, Sozio P, Cerasa LS Molecules (Basel, Switzerland) 2008 0
Assessment of neuroimaging techniques as biomarkers of the progression of Parkin [PMID:14597329] Brooks DJ, Frey KA, Marek KL, Oakes D, P Experimental neurology 2003 0